642 related articles for article (PubMed ID: 27533032)
21. Pharmacological Characters of Oliceridine, a μ-Opioid Receptor G-Protein-Biased Ligand in Mice.
Liang DY; Li WW; Nwaneshiudu C; Irvine KA; Clark JD
Anesth Analg; 2019 Nov; 129(5):1414-1421. PubMed ID: 30044299
[TBL] [Abstract][Full Text] [Related]
22. 'Biased' opioids could yield safer pain relief.
Wadman M
Science; 2017 Nov; 358(6365):847-848. PubMed ID: 29146784
[No Abstract] [Full Text] [Related]
23. Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.
Lu Z; Xu J; Xu M; Rossi GC; Majumdar S; Pasternak GW; Pan YX
Anesth Analg; 2018 Mar; 126(3):1050-1057. PubMed ID: 28991118
[TBL] [Abstract][Full Text] [Related]
24. Enhanced morphine analgesia in mice lacking beta-arrestin 2.
Bohn LM; Lefkowitz RJ; Gainetdinov RR; Peppel K; Caron MG; Lin FT
Science; 1999 Dec; 286(5449):2495-8. PubMed ID: 10617462
[TBL] [Abstract][Full Text] [Related]
25. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.
Yi SP; Kong QH; Li YL; Pan CL; Yu J; Cui BQ; Wang YF; Wang GL; Zhou PL; Wang LL; Gong ZH; Su RB; Shen YH; Yu G; Chang KJ
Acta Pharmacol Sin; 2017 Jul; 38(7):977-989. PubMed ID: 28502978
[TBL] [Abstract][Full Text] [Related]
26. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
27. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat.
Araldi D; Ferrari LF; Levine JD
Neuroscience; 2018 Dec; 394():60-71. PubMed ID: 30342200
[TBL] [Abstract][Full Text] [Related]
28. Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia.
Sánchez-Blázquez P; Gómez-Serranillos P; Garzón J
Brain Res Bull; 2001 Jan; 54(2):229-35. PubMed ID: 11275413
[TBL] [Abstract][Full Text] [Related]
29. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
[TBL] [Abstract][Full Text] [Related]
30. The G Protein Signal-Biased Compound TRV130; Structures, Its Site of Action and Clinical Studies.
Miyano K; Manabe S; Komatsu A; Fujii Y; Mizobuchi Y; Uezono E; Ohshima K; Nonaka M; Kuroda Y; Narita M; Uezono Y
Curr Top Med Chem; 2020; 20(31):2822-2829. PubMed ID: 33115393
[TBL] [Abstract][Full Text] [Related]
31. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
Wang D; Chen T; Zhou X; Couture R; Hong Y
Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
[TBL] [Abstract][Full Text] [Related]
33. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
[TBL] [Abstract][Full Text] [Related]
34. Discovery of DS34942424: An orally potent analgesic without mu opioid receptor agonist activity.
Arita T; Asano M; Kubota K; Domon Y; Machinaga N; Shimada K
Bioorg Med Chem; 2020 Nov; 28(21):115714. PubMed ID: 33065431
[TBL] [Abstract][Full Text] [Related]
35. Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.
Váradi A; Marrone GF; Palmer TC; Narayan A; Szabó MR; Le Rouzic V; Grinnell SG; Subrath JJ; Warner E; Kalra S; Hunkele A; Pagirsky J; Eans SO; Medina JM; Xu J; Pan YX; Borics A; Pasternak GW; McLaughlin JP; Majumdar S
J Med Chem; 2016 Sep; 59(18):8381-97. PubMed ID: 27556704
[TBL] [Abstract][Full Text] [Related]
36. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.
Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW
ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914
[TBL] [Abstract][Full Text] [Related]
37. Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine.
Dahan A; van Dam CJ; Niesters M; van Velzen M; Fossler MJ; Demitrack MA; Olofsen E
Anesthesiology; 2020 Sep; 133(3):559-568. PubMed ID: 32788558
[TBL] [Abstract][Full Text] [Related]
38. Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.
Weibel R; Reiss D; Karchewski L; Gardon O; Matifas A; Filliol D; Becker JA; Wood JN; Kieffer BL; Gaveriaux-Ruff C
PLoS One; 2013; 8(9):e74706. PubMed ID: 24069332
[TBL] [Abstract][Full Text] [Related]
39. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.
Kandasamy R; Hillhouse TM; Livingston KE; Kochan KE; Meurice C; Eans SO; Li MH; White AD; Roques BP; McLaughlin JP; Ingram SL; Burford NT; Alt A; Traynor JR
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846240
[TBL] [Abstract][Full Text] [Related]
40. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
